1505MO Improving cancer care through broader access to quality biomarker testing: An IQN Path, ECPC and EFPIA initiative

Volume: 32, Pages: S1103 - S1104
Published: Sep 1, 2021
Abstract
Predictive biomarkers are essential for selecting the best therapeutic strategy in cancer patients. Yet, the promise of superior treatment outcomes cannot be realised if patients do not have access to high quality biomarker testing. The International Quality Network for Pathology (IQN Path ASBL), the European Cancer Patient Coalition (ECPC) and the European Federation of Pharmaceuticals Industries and Associations (EFPIA) launched an initiative...
Paper Details
Title
1505MO Improving cancer care through broader access to quality biomarker testing: An IQN Path, ECPC and EFPIA initiative
Published Date
Sep 1, 2021
Volume
32
Pages
S1103 - S1104
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.